INVO Bioscience, Inc. Uncategorized Contracts & Agreements

Standard Merchant Cash Advance Agreement (Filed With SEC on October 1, 2024)

Standard Merchant Cash Advance Agreement (Filed With SEC on September 1, 2023)

Goren Temporary Salary Reduction letter (Filed With SEC on August 14, 2023)

Shum Temporary Salary Reduction letter (Filed With SEC on August 14, 2023)

Directed Equity Transfer Agreement (Filed With SEC on August 11, 2023)

Physician Liaison Agreement (Filed With SEC on August 11, 2023)

Letter Agreement dated July 31, 2023 (Filed With SEC on August 2, 2023)

Amended and Restated Letter Agreement between INVO Bioscience, Inc. and JAG Multi Investments LLC (Filed With SEC on July 21, 2023)

Standard Merchant Cash Advance Agreement between INVO Bioscience Inc. and Cedar Advance LLC (Filed With SEC on July 21, 2023)

Letter Agreement between INVO Bioscience, Inc. and JAG Multi Investments LLC (Filed With SEC on July 13, 2023)

Payoff Commitment Agreement and Confession of Judgment dated July7, 2023, between the Company and Armistice (Filed With SEC on July 7, 2023)

TA Letter dated February 17, 2023 (Filed With SEC on February 23, 2023)

TA Letter dated February 3, 2023 (Filed With SEC on February 9, 2023)

Placement Agent Agreement, dated October 1, 2021, between the Company and the Placement Agent (Filed With SEC on October 5, 2021)

INVO IP Sublicense Agreement (Filed With SEC on June 30, 2021)

LLC Agreement (Filed With SEC on June 30, 2021)

JV Agreement (Filed With SEC on June 30, 2021)

Partnership Agreement (Filed With SEC on April 13, 2021)

Placement Agent Agreement (Filed With SEC on June 26, 2020)

Lionshare Ventures Revised Agreement (Filed With SEC on August 14, 2009)

Red Chip Securities, Inc. Agreement (Filed With SEC on May 15, 2009)

Wakabayashi Fund, LLC Agreement (Filed With SEC on May 15, 2009)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on December 12, 2008)

SHAREEXCHANGE AGREEMENT (Filed With SEC on December 12, 2008)